175 related articles for article (PubMed ID: 33207264)
21. Senecavirus A.
Segalés J; Barcellos D; Alfieri A; Burrough E; Marthaler D
Vet Pathol; 2017 Jan; 54(1):11-21. PubMed ID: 27371541
[TBL] [Abstract][Full Text] [Related]
22. Experimental evidence for occurrence of putative copy-choice recombination between two Senecavirus A genomes.
Liu F; Wang Q; Meng H; Zhao D; Hao X; Zhang S; Lu J; Shan H
Vet Microbiol; 2022 Aug; 271():109487. PubMed ID: 35714527
[TBL] [Abstract][Full Text] [Related]
23. The use of the NIS reporter gene for optimizing oncolytic virotherapy.
Miller A; Russell SJ
Expert Opin Biol Ther; 2016; 16(1):15-32. PubMed ID: 26457362
[TBL] [Abstract][Full Text] [Related]
24. Generation of recombinant measles virus containing the wild-type P gene to improve its oncolytic efficiency.
Alizadeh R; Ghanei M; Arashkia A; Dorostkar R; Azadmanesh K
Microb Pathog; 2019 Oct; 135():103631. PubMed ID: 31381964
[No Abstract] [Full Text] [Related]
25. Real-Time Visualization and Quantification of Oncolytic M1 Virus
Zhu W; Liang J; Tan J; Guo L; Cai J; Hu J; Yan G; Liu Y; Zhang J; Song D; Dan J; Wong CW; Su X; Qiu P; Lin Y
Hum Gene Ther; 2021 Feb; 32(3-4):158-165. PubMed ID: 33504253
[TBL] [Abstract][Full Text] [Related]
26. Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells.
Jiang K; Song C; Kong L; Hu L; Lin G; Ye T; Yao G; Wang Y; Chen H; Cheng W; Barr MP; Liu Q; Zhang G; Ding C; Meng S
BMC Cancer; 2018 Jul; 18(1):746. PubMed ID: 30021550
[TBL] [Abstract][Full Text] [Related]
27. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
[TBL] [Abstract][Full Text] [Related]
28. A Novel Live Attenuated Vaccine Candidate Protects Against Heterologous
Sharma B; Fernandes MHV; de Lima M; Joshi LR; Lawson S; Diel DG
Front Immunol; 2019; 10():2660. PubMed ID: 31849928
[No Abstract] [Full Text] [Related]
29. Generation of Genetically RGD σ1-Modified Oncolytic Reovirus That Enhances JAM-A-Independent Infection of Tumor Cells.
Kawagishi T; Kanai Y; Nouda R; Fukui I; Nurdin JA; Matsuura Y; Kobayashi T
J Virol; 2020 Nov; 94(23):. PubMed ID: 32907973
[TBL] [Abstract][Full Text] [Related]
30. Senecavirus A as an Oncolytic Virus: Prospects, Challenges and Development Directions.
Luo D; Wang H; Wang Q; Liang W; Liu B; Xue D; Yang Y; Ma B
Front Oncol; 2022; 12():839536. PubMed ID: 35371972
[TBL] [Abstract][Full Text] [Related]
31. Motif mutations in pseudoknot stem I upstream of start codon in Senecavirus A genome: Impacts on activity of viral IRES and on rescue of recombinant virus.
Liu F; Wang N; Wang Q; Shan H
Vet Microbiol; 2021 Nov; 262():109223. PubMed ID: 34507016
[TBL] [Abstract][Full Text] [Related]
32. Senecavirus-Specific Recombination Assays Reveal the Intimate Link between Polymerase Fidelity and RNA Recombination.
Li C; Wang H; Shi J; Yang D; Zhou G; Chang J; Cameron CE; Woodman A; Yu L
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996084
[TBL] [Abstract][Full Text] [Related]
33. Highly Potent Cell-Permeable and Impermeable NanoLuc Luciferase Inhibitors.
Walker JR; Hall MP; Zimprich CA; Robers MB; Duellman SJ; Machleidt T; Rodriguez J; Zhou W
ACS Chem Biol; 2017 Apr; 12(4):1028-1037. PubMed ID: 28195704
[TBL] [Abstract][Full Text] [Related]
34. Engineering His-Tagged Senecavirus A for One-Step Purification of Viral Antigens.
Fan J; Xiao P; Kong D; Liu X; Meng L; An T; Cai X; Wang H; Yu L
Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214628
[TBL] [Abstract][Full Text] [Related]
35. Quantitative Assessment of the Health Risk for Livestock When Animal Viruses Are Applied in Human Oncolytic Therapy: A Case Study for Seneca Valley Virus.
Schijven J; Brizee S; Teunis P; de Vos C; Eblé P; Rutjes S
Risk Anal; 2019 May; 39(5):982-991. PubMed ID: 30395685
[TBL] [Abstract][Full Text] [Related]
36. Oncolytic Virotherapy by HSV.
Watanabe D; Goshima F
Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
[TBL] [Abstract][Full Text] [Related]
37. A NanoLuc Luciferase Reporter Pseudorabies Virus for Live Imaging and Quantification of Viral Infection.
Wang Y; Wu H; Wang B; Qi H; Jin Z; Qiu HJ; Sun Y
Front Vet Sci; 2020; 7():566446. PubMed ID: 33195544
[TBL] [Abstract][Full Text] [Related]
38. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.
Haddad D; Chen N; Zhang Q; Chen CH; Yu YA; Gonzalez L; Aguilar J; Li P; Wong J; Szalay AA; Fong Y
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S665-74. PubMed ID: 22258815
[TBL] [Abstract][Full Text] [Related]
39. Senecavirus A 3C Protease Mediates Host Cell Apoptosis Late in Infection.
Fernandes MHV; Maggioli MF; Otta J; Joshi LR; Lawson S; Diel DG
Front Immunol; 2019; 10():363. PubMed ID: 30918505
[TBL] [Abstract][Full Text] [Related]
40. Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.
Sugiyama T; Yoneda M; Kuraishi T; Hattori S; Inoue Y; Sato H; Kai C
Gene Ther; 2013 Mar; 20(3):338-47. PubMed ID: 22717740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
